Latest news
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised - TradingViewTradingView · Fri, 07 Aug 2026 18:18:00 GMTNovavax, Inc. Stock 12‑Month Price Target Cut to $13.75, Implies 78% Upside - TradingViewTradingView · Fri, 07 Aug 2026 14:20:21 GMTNVAX Stock Holds Steady As Novavax Lifts Revenue Outlook On Licensing Pivot — Retail Eyes Buyout, More Partnership Deals - TradingViewTradingView · Thu, 06 Aug 2026 21:29:05 GMTNVAX: Q2 2026 revenue reached $57M, with strong Matrix-M growth and major partnership milestones ahead - TradingViewTradingView · Thu, 06 Aug 2026 14:54:38 GMTNovavax, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 14:07:51 GMTNovavax (NASDAQ:NVAX) Exceeds Q2 CY2026 Expectations - TradingViewTradingView · Thu, 06 Aug 2026 13:18:18 GMTNVAX: Q2 2026 revenue dropped 76% year-over-year, but product sales and Sanofi milestones advanced - TradingViewTradingView · Thu, 06 Aug 2026 12:03:41 GMTNovavax Reports Second Quarter 2026 Financial Results and Operational Highlights - TradingViewTradingView · Thu, 06 Aug 2026 12:00:00 GMT